Li Kong

机构：Anhui Medical University, Nankai University, Shanghai Normal University, State Key Laboratory of Oil and Gas Reservoir Geology and Exploitation, Daqing Oilfield General Hospital, Tianjin Central Hospital of Gynecology Obstetrics, Huazhong University of Science and Technology · ORCID：0000-0003-2486-7875

发表论文 67 篇 · 总被引 2875 次 · h-index 20

代表论文

• Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial (2024 · Signal Transduction and Targeted Therapy · 被引 29)
• Efficacy of median nerve electrical stimulation on the recovery of patients with consciousness disorders: a systematic review and meta-analysis (2022 · Journal of International Medical Research · 被引 16)
• The impact of COVID-19 pandemic on hand hygiene compliance of healthcare workers in a tertiary hospital in East China (2023 · Frontiers in Medicine · 被引 13)
• Gut microbiome characteristics in individuals across different stages of schizophrenia spectrum disorders: A systematic review and meta-analysis (2025 · Neuroscience & Biobehavioral Reviews · 被引 12)
• Effectiveness of nirsevimab immunization against RSV infection in preterm infants: a systematic review and meta-analysis (2025 · Frontiers in Immunology · 被引 12)
• Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study (2024 · EClinicalMedicine · 被引 10)